Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Primary Hip Prosthesis System

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTIPMED Medical Device Manufacturing Ltd. Co.

About this trial

This is a multicenter, prospective, observational, post-market clinical follow-up (PMCF) study designed to evaluate the safety and clinical performance of the Tipmed™ Primary Hip Prosthesis System in adult subjects undergoing primary hip arthroplasty. The study aims to gather real-world clinical evidence on the 24-month post-operative safety profile, potential complications, and functional outcomes of the device during routine clinical practice.

Eligibility criteria

Qualifiers

Individuals aged 18 years and older,

Male or female participants,

Subjects who have undergone Primary Hip Arthroplasty (either total or partial) for any indication,

Subjects in whose surgical procedure the Tipmed™ Primary Hip Prosthesis System components were utilized.

Disqualifiers

Subjects currently participating in any other interventional clinical trial.

Trial design

Treatments tested in this trial

  • Tipmed™ Primary Hip Prosthesis System

Treatment groups

101 Participants
are divided into 1 treatment group